WRS Group, LLC (WRS), a privately held company based in Ann Arbor, Michigan, announced today that it has entered into a definitive agreement with Avanos Medical, Inc. (NYSE: AVNS) to acquire substantially all assets and rights related to Avanos' US Game Ready® orthopedic rental business. WRS Group, a national leader in orthopedic pain management and recovery solutions, specializes in cold and compression therapy for patients recovering from injury or surgery. The acquisition

Catheter Precision, Inc. a US based medical device company and a leading developer of innovative solutions for cardiac procedures, is pleased to announce a strategic distribution agreement with FuMedica AG, a premier Swiss medical device distributor. This partnership will introduce Catheter Precision’s LockeT suture retention device to hospitals and clinics across Switzerland. LockeT is a novel suture retention tool designed to simplify and secure the closure of vascular acces

Merit Medical Systems, Inc. a global leader of healthcare technology, today announced it has signed a definitive asset purchase agreement with Pentax of America, Inc., a subsidiary of PENTAX® Medical, Inc., to acquire the C2 CryoBalloon™ device and related technology. The closing of the proposed transaction is expected to occur during the fourth quarter of 2025, subject to the receipt or waiver (in accordance with the provisions of the asset purchase agreement) of certain custo

Scanogen Inc., a molecular diagnostics company pioneering next-generation technologies for infectious disease detection, today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation for the company’s rapid assay designed to identify bloodstream infection pathogens directly from patient samples. The FDA’s Breakthrough Device designation recognizes technologies that have the potential to provide more effective diagnosis or tr

Accuray Incorporated announced today that 5D Clinics has treated the first patients in the city of Melbourne, Australia, using the CyberKnife S7™ System. 5D Clinics and joint venture partner Icon Group will open and operate CyberKnife System centers across Australia*, with the goal of making it easier for cancer patients to obtain state-of-the-art precision robotic stereotactic body radiation therapy (SBRT) and stereotactic radio surgery (SRS) treatments closer to home. With an ini

Tebra, a leading healthcare technology platform, today announced the launch of AI Review Replies and AI Review Insights, two groundbreaking artificial intelligence features integrated natively within its EHR+ Patient Experience package. These industry-first innovations make Tebra the only EHR software solution offering native AI-powered sentiment analysis and automated review response capabilities, positioning healthcare practices to better manage their online reputation while maint

AtaCor Medical, Inc., a privately-held medical device company focused on transforming cardiac rhythm management systems, announced today that it has entered into a financing of up to $75 million. The proceeds will fund the company's U.S. FDA Pivotal Study evaluating AtaCor's parasternal extravascular implantable cardioverter-defibrillator (EV-ICD) system for the treatment of life-threatening ventricular tachyarrhythmias. "There is a clear and growing need for extravascu

ScreenPoint Medical today announced that its Transpara® breast imaging AI solution has been selected as the technology of choice for the PRISM (Pragmatic Randomized Trial of Artificial Intelligence for Screening Mammography) Trial, a landmark randomized controlled trial funded by the Patient-Centered Outcomes Research Institute (PCORI). Fueled by a $16 million award, this is the first large-scale trial in the United States to rigorously evaluate the role of artificial intelligence (AI) in

FlyteHealth, a leader in virtual cardiometabolic care, and Heartbeat Health, the nation's leading virtual-first cardiology provider, today announced a strategic partnership, launching a bundled program combining their expertise into a seamless offering. This solution creates one entry point for employers and payors to provide comprehensive care—from managing conditions like pre-diabetes, hypertension, and hyperlipidemia with FlyteHealth to addressing cardiovascular disease

Stereotaxis a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced successful first procedures by physicians at Erasmus University Medical Center in Rotterdam, The Netherlands, using the advanced Genesis Robotic Magnetic Navigation System. “We have long recognized the clinical benefits of robotics, and are delighted to be the first in The Netherlands to make the Genesis robotic system available to cardiovascular